AI assistant
DEXCOM INC — Director's Dealing 2011
Sep 19, 2011
30198_dirs_2011-09-19_15343a12-9163-467c-9513-4fdbd37f7a2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2011-09-15
Reporting Person: DOORDAN MARTIN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-15 | Common Stock | P | 2000 | $12.3539 | Acquired | 23641 | Direct |
Footnotes
F1: The number of securities beneficially owned by Mr. Doordan include 1,967 restricted share units and 19,674 restricted share units. Additional information on the restricted share units is provided below.
On May 26, 2011, the Date of Grant, Mr. Doordan received 1,967 restricted share units- RSUs. The RSUs are restricted and will vest in full on the one year anniversary of the Date of Grant, or May 26, 2012. The RSUs represent a contingent right to receive one share of DexCom, Inc. common stock. As of the date of this filing, no RSUs have vested.
On May 26, 2011, the Date of Grant, Mr. Doordan received 19,674 restricted share units-RSUs. The RSUs are restricted and subject to vesting in three equal annual installments from the Date of Grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. As of the date of this filing, no RSUs have vested.